This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Fergal Casey: Innovator in Cancer Therapy Prediction
Introduction
Fergal Casey is an accomplished inventor based in Pleasanton, CA (US). He has made significant contributions to the field of cancer therapy through his innovative methods. His work focuses on improving patient outcomes in colorectal cancer treatment.
Latest Patents
Fergal Casey holds a patent for a method of predicting response to therapy by assessing tumor genetic heterogeneity. This invention involves measuring tumor genetic heterogeneity through the analysis of circulating tumor DNA from a patient's sample. This groundbreaking method aims to enhance the accuracy of therapy predictions for colorectal cancer patients.
Career Highlights
Throughout his career, Fergal has worked with notable companies such as Roche Sequencing Solutions, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
Fergal has collaborated with talented individuals in his field, including coworkers John Lee and John Palma. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Fergal Casey's contributions to cancer therapy prediction demonstrate his commitment to improving patient care. His innovative methods and collaborations highlight the importance of research in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile